185 related articles for article (PubMed ID: 1386263)
1. Ultrastructural changes in onychomycosis during the treatment with bifonazole/urea ointment.
Fritsch H; Stettendorf S; Hegemann L
Dermatology; 1992; 185(1):32-6. PubMed ID: 1386263
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
3. Onychomycosis in children: treatment with bifonazole-urea.
Bonifaz A; Ibarra G
Pediatr Dermatol; 2000; 17(4):310-4. PubMed ID: 10990584
[TBL] [Abstract][Full Text] [Related]
4. Treatment of onychomycosis with a bifonazole-urea combination.
Hardjoko FS; Widyanto S; Singgih I; Susilo J
Mycoses; 1990 Apr; 33(4):167-71. PubMed ID: 2146498
[TBL] [Abstract][Full Text] [Related]
5. Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole.
Torres-Rodríguez JM; Madrenys N; Nicolás MC
Mycoses; 1991; 34(11-12):499-504. PubMed ID: 1840471
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of onychomycosis using 40% urea with 1% bifonazole].
Shemer A; Bergman R; Cohen A; Friedman-Birnbaum R
Harefuah; 1992 Feb; 122(3):159-60. PubMed ID: 1532948
[TBL] [Abstract][Full Text] [Related]
7. Non-traumatic removal of the nail and simultaneous treatment of onychomycosis.
Nolting S
Dermatologica; 1984; 169 Suppl 1():117-20. PubMed ID: 6241158
[TBL] [Abstract][Full Text] [Related]
8. The topical treatment of onychomycosis using a new combined urea/imidazole preparation.
Hay RJ; Roberts DT; Doherty VR; Richardson MD; Midgley G
Clin Exp Dermatol; 1988 May; 13(3):164-7. PubMed ID: 2977574
[No Abstract] [Full Text] [Related]
9. Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.
Cutrín Gómez E; Anguiano Igea S; Delgado-Charro MB; Gómez Amoza JL; Otero Espinar FJ
Eur J Pharm Biopharm; 2018 Jul; 128():48-56. PubMed ID: 29673870
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.
Tietz HJ; Hay R; Querner S; Delcker A; Kurka P; Merk HF
Mycoses; 2013 Jul; 56(4):414-21. PubMed ID: 23586591
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Schaller M; Sigurgeirsson B; Sarkany M
Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
[TBL] [Abstract][Full Text] [Related]
12. Treatment of onychomycosis by partial nail avulsion and topical miconazole.
Rollman O
Dermatologica; 1982 Jul; 165(1):54-61. PubMed ID: 6214436
[TBL] [Abstract][Full Text] [Related]
13. Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
Friedman-Birnbaum R; Cohen A; Shemer A; Bitterman O; Bergman R; Stettendorf S
Int J Dermatol; 1997 Jan; 36(1):67-9. PubMed ID: 9071624
[TBL] [Abstract][Full Text] [Related]
14. Onychomycosis: burden of disease and the role of topical antifungal treatment.
Daniel RC
J Drugs Dermatol; 2013 Nov; 12(11):1263-6. PubMed ID: 24196334
[TBL] [Abstract][Full Text] [Related]
15. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy and tolerability of four weeks bifonazole treatment after nail ablation with 40% urea in mild to moderate distal subungual onychomycosis.
Piraccini BM; Bruni F; Alessandrini A; Starace M
G Ital Dermatol Venereol; 2016 Feb; 151(1):32-6. PubMed ID: 26472342
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis.
Bonifaz A; Guzmán A; Garcia C; Sosa J; Saúl A
Int J Dermatol; 1995 Jul; 34(7):500-3. PubMed ID: 7591419
[No Abstract] [Full Text] [Related]
18. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
Cook-Bolden FE; Lin T
Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
[TBL] [Abstract][Full Text] [Related]
19. [Trichophyton rubrum onychomycosis with secondary Aspergillus versicolor infection in a 12-year-old girl: successful topical therapy with terbinafine-urea ointment].
Mayser PA; Gries A; Hamrouni N
Hautarzt; 2014 Jul; 65(7):628-32. PubMed ID: 24817253
[TBL] [Abstract][Full Text] [Related]
20. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
Bohn M; Kraemer K
J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
